Upstream nickel resource development projects gradually reaching full production zhejiang huayou cobalt Q3 net profit hits historical high for the same period | interpretations

①Benefiting from the simultaneous increase in the volume and price of nickel products, zhejiang huayou cobalt's performance has stabilized, with a net profit in Q3 this year reaching the highest level for the same period in a single quarter; ②In the first three quarters of this year, zhejiang huayou cobalt's net profit has already reached 90% of the net profit for the entire previous year, and the full-year performance may exceed market expectations; ③In the first three quarters of this year, zhejiang huayou cobalt's financial expenses increased by 88.64% year-on-year, possibly related to the high corporate assets-liabilities ratio.

cls.cnOct 18 11:31 ET

Zijin Mining Group's performance in the first three quarters increased by more than 50%, planning to invest approximately 8.4 billion yuan in developing copper mining projects in Tibet | interpretations

①Benefiting from the simultaneous increase in the volume and price of nonferrous metals products, zijin mining group's net income in the first three quarters increased by more than fifty percent; ②The company plans to invest over 8 billion yuan in Tibets Zhuono Copper Mine, which is expected to start production within two years.

cls.cnOct 18 11:16 ET

The rising prices of medicinal materials such as Atractylodes macrocephala are increasing costs. Jianmin Pharmaceutical Group's net income in Q3 fell by nearly fifty percent | Interpretations

①In the third quarter, jianmin pharmaceutical group's revenue was 0.872 billion yuan, a decrease of 8.83% year-on-year; net income was 82.2581 million yuan, a decrease of 49.46% year-on-year. ②The price of Atractylodes macrocephala has more than quadrupled in two years, and Atractylodes macrocephala is an important raw material for many of the company's main products. The increase in traditional chinese medicine prices has led to an increase in the company's procurement costs. ③Chairman He Qin of the company is currently unable to perform his duties as chairman due to personal health reasons.

cls.cnOct 18 10:17 ET

Guangzhou Automobile Group is striving to seize the "straw" of going overseas.

Seek a new way out.

wallstreetcnOct 18 09:25 ET

Shanghai Friendess Electronic Technology Corporation: Asia Vets Welding Control System has achieved partial batch delivery, with points established in South Korea and overseas sales promoted | Direct hit on earnings conference

①The chairman stated that currently asia vets welding control system is gradually being promoted, and many first and second-tier siasun robot&automation manufacturers and integrators have already adopted the company's solutions, with good feedback. ②The company is enhancing the scale effect of products and optimizing product models, such as simplifying some hardware, and launching more efficient models of products.

cls.cnOct 18 08:54 ET

Is being included in medical insurance a lifesaving straw? Shanghai Yizhong's core products cannot enter hospitals, investors inquire about the progress of national talks | Direct hitting earnings conference

①Due to the closure of the self-funded pharmacy in the core hospital, Shanghai Yizhong's self-paid product paclitaxel micelles, which are not included in medical insurance, cannot be admitted to the hospital, impacting its performance in the first half of the year. ②Shanghai Yizhong is preparing for the paclitaxel micelles to participate in this year's medical insurance negotiations. In response to this matter, the chairman stated that the national medical insurance negotiation progress for paclitaxel micelles is proceeding normally, and the final negotiation result will be announced in subsequent disclosures.

cls.cnOct 18 06:00 ET